Trial intelligence / Profile preview

Rectal versus oral diclofenac for post-episiotomy perineal pain

PACTR202308864630455Phase 3Not yet recruiting

Sponsor
Princeba Tamunobelema Amachree
Start
Aug 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of diclofenac in perineal pain (2 arms), sponsored by Princeba Tamunobelema Amachree. Primary endpoint: Difference in pain score between groups. Planned start Aug 2023; status: not yet recruiting.

02

Drugs

diclofenac
03

Conditions

perineal pain

Beyond the preview

Go deeper on PACTR202308864630455.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202308864630455.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call